FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
ADMA Biologics (NASDAQ: ADMA) reported Q4 EPS of ($0.58), versus $0.50 reported last year. Revenue for the quarter came in at $524 thousand, versus $30 million reported last year.
For earnings history and earnings-related data on ADMA Biologics (ADMA) click here.
... More
